EP3508204
QUINAZOLIN-8-YL DERIVATIVES FOR USE IN METHODS OF TREATING MELANOMA, NON-SMALL CELL LUNG CANCER, THYROID CANCER, OVARIAN CANCER, OR COLON CANCER
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
22.8.2014EP published:
11.2.2026EP application number:
19157227.0
EPO information:
European Patent Register
Max expiry date:
21.8.2034Expiry date:
21.8.2026
Title in English:
QUINAZOLIN-8-YL DERIVATIVES FOR USE IN METHODS OF TREATING MELANOMA, NON-SMALL CELL LUNG CANCER, THYROID CANCER, OVARIAN CANCER, OR COLON CANCERLanguage of the patent:
English
Timeline
Today
22.8.2014EP application
11.2.2026EP Publication
21.8.2026Expires
Owner
Name:
Neupharma, Inc.Address:
1175 Chess Drive Suite 206, Foster City, CA 94404, US
Inventor
Name:
QIAN, XiangpingAddress:
Foster City, CA 94404, US
Name:
ZHU, Yong-LiangAddress:
Fremont, CA 94539, US
Priority
Number:
201361869596 PDate:
23.8.2013Country:
US
Number:
201361900283 PDate:
5.11.2013Country:
US
Number:
201462000946 PDate:
20.5.2014Country:
US
Classification
Categories:
A61K 31/519, C07D 471/04